Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/01/25
End: 09/01/29
Due: 09/01/30
Phase: N/A
Priority: Normal
Start: 04/01/27
End: 03/31/32
Due: 03/31/33
A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder
Phase: N/A
Priority: Normal
Start: 10/01/25
End: 12/01/27
Due: 12/01/28
Phase: N/A
Priority: Normal
Start: 04/11/23
End: 08/31/25
Due: 08/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Phase I Study of the Interaction of Alcohol With Oral AFA-281 in Healthy Volunteers | NCT06719908 | Afasci Inc | user2@example.com | None | 2025-07-01 | 2029-09-01 | 2030-09-01 | - | - | 2025-07-14 |
| Safety and Efficacy Study on AFA-281 for the Treatment of Low Back Pain | NCT06649747 | Afasci Inc | user2@example.com | None | 2027-04-01 | 2032-03-31 | 2033-03-31 | - | - | 2025-07-14 |
| A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder | NCT06710431 | Afasci Inc | user2@example.com | None | 2025-10-01 | 2027-12-01 | 2028-12-01 | - | - | 2025-07-14 |
| Phase I Single Ascending Dose and Multiple Ascending Doses of Oral AFA-281 in Healthy Volunteers | NCT05547503 | Afasci Inc | user2@example.com | None | 2023-04-11 | 2025-08-31 | 2026-08-31 | - | - | 2025-07-14 |